KRW 17490.0
(-3.95%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 28.26 Billion KRW | -2.8% |
2022 | 29.07 Billion KRW | 26.79% |
2021 | 22.93 Billion KRW | 28.55% |
2020 | 17.83 Billion KRW | 20.44% |
2019 | 14.81 Billion KRW | 18.22% |
2018 | 12.52 Billion KRW | 18.06% |
2017 | 10.61 Billion KRW | 11.55% |
2016 | 9.51 Billion KRW | 0.96% |
2015 | 9.42 Billion KRW | 0.0% |
2013 | 8.33 Billion KRW | -9.47% |
2012 | 9.21 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 27.05 Billion KRW | -5.31% |
2024 Q1 | 28.56 Billion KRW | 1.09% |
2023 Q2 | 29.15 Billion KRW | 9.81% |
2023 Q3 | 30.05 Billion KRW | 3.1% |
2023 FY | 28.26 Billion KRW | -2.8% |
2023 Q4 | 28.26 Billion KRW | -5.97% |
2023 Q1 | 26.54 Billion KRW | -8.69% |
2022 Q1 | 22.78 Billion KRW | -0.65% |
2022 Q4 | 29.07 Billion KRW | -1.38% |
2022 Q3 | 29.48 Billion KRW | 10.23% |
2022 Q2 | 26.74 Billion KRW | 17.39% |
2022 FY | 29.07 Billion KRW | 26.79% |
2021 FY | 22.93 Billion KRW | 28.55% |
2021 Q3 | 22.52 Billion KRW | 6.42% |
2021 Q4 | 22.93 Billion KRW | 1.82% |
2021 Q1 | 18.37 Billion KRW | 2.98% |
2021 Q2 | 21.16 Billion KRW | 15.19% |
2020 Q4 | 17.83 Billion KRW | -4.66% |
2020 FY | 17.83 Billion KRW | 20.44% |
2020 Q3 | 18.71 Billion KRW | 8.08% |
2020 Q2 | 17.31 Billion KRW | 1.97% |
2020 Q1 | 16.97 Billion KRW | 14.62% |
2019 Q2 | 12.46 Billion KRW | -2.36% |
2019 FY | 14.81 Billion KRW | 18.22% |
2019 Q4 | 14.81 Billion KRW | -2.1% |
2019 Q3 | 15.12 Billion KRW | 21.36% |
2019 Q1 | 12.76 Billion KRW | 1.9% |
2018 FY | 12.52 Billion KRW | 18.06% |
2018 Q4 | 12.52 Billion KRW | 19.85% |
2018 Q3 | 10.45 Billion KRW | 2.92% |
2018 Q2 | 10.15 Billion KRW | -0.42% |
2018 Q1 | 10.2 Billion KRW | -3.88% |
2017 FY | 10.61 Billion KRW | 11.55% |
2017 Q1 | 9.49 Billion KRW | -0.25% |
2017 Q2 | 10.05 Billion KRW | 5.99% |
2017 Q4 | 10.61 Billion KRW | 0.0% |
2017 Q3 | - KRW | -100.0% |
2016 Q2 | 10.48 Billion KRW | 3.61% |
2016 FY | 9.51 Billion KRW | 0.96% |
2016 Q4 | 9.51 Billion KRW | -13.51% |
2016 Q3 | 11 Billion KRW | 4.92% |
2016 Q1 | 10.11 Billion KRW | 7.38% |
2015 Q4 | 9.42 Billion KRW | 0.0% |
2015 FY | 9.42 Billion KRW | 0.0% |
2014 Q3 | 8.68 Billion KRW | -12.46% |
2014 Q1 | 8.37 Billion KRW | 0.48% |
2014 Q2 | 9.92 Billion KRW | 18.46% |
2013 Q2 | 8.48 Billion KRW | -6.61% |
2013 FY | 8.33 Billion KRW | -9.47% |
2013 Q4 | 8.33 Billion KRW | -5.95% |
2013 Q3 | 8.86 Billion KRW | 4.56% |
2013 Q1 | 9.08 Billion KRW | -1.42% |
2012 Q4 | 9.21 Billion KRW | 9.7% |
2012 FY | 9.21 Billion KRW | 0.0% |
2012 Q3 | 8.39 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Co., Ltd. | 11.42 Billion KRW | -147.439% |
iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -2695.097% |
Bioneer Corporation | 41.35 Billion KRW | 31.66% |
Anterogen.Co.,Ltd. | 1.91 Billion KRW | -1379.261% |
MEDIPOST Co., Ltd. | 14.51 Billion KRW | -94.679% |
CrystalGenomics, Inc. | 1.55 Billion USD | -1717.694% |
Helixmith Co., Ltd | 914.11 Million KRW | -2991.666% |
Chabiotech Co.,Ltd. | 34.11 Billion KRW | 17.162% |
Medy-Tox Inc. | 59.61 Billion KRW | 52.596% |
Peptron, Inc. | 172.18 Million KRW | -16313.139% |
Amicogen, Inc. | 46.83 Billion KRW | 39.661% |
Genexine, Inc. | 3.8 Billion KRW | -642.365% |
HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -429.654% |
LegoChem Biosciences, Inc. | 196.83 Million KRW | -14257.933% |
ALTEOGEN Inc. | 1.06 Billion KRW | -2545.304% |
PharmaResearch Co., Ltd. | 50.23 Billion KRW | 43.739% |
SillaJen, Inc. | 1.21 Billion KRW | -2230.593% |
JETEMA, Co., Ltd. | 12.74 Billion KRW | -121.816% |
OliX Pharmaceuticals,Inc | 468.4 Million KRW | -5933.474% |
Genomictree Inc. | 496.53 Million KRW | -5591.755% |
MedPacto, Inc. | 620.00 KRW | -4558282216.613% |
D&D Pharmatech | 3.45 Billion KRW | -719.118% |
EASY BIO,Inc. | 25.93 Billion KRW | -8.955% |
GI Innovation, Inc. | - KRW | -Infinity% |